SCD1 inhibition enhances the effector functions of CD8 + T cells via ACAT1 ‐dependent reduction of esterified cholesterol
Cancer Science · 2024
DOI: 10.1111/cas.15999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Toshihiro Sugi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Oleic Acid, Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Kobayashi Foundation for Cancer Research, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
We previously reported that the inhibition of stearoyl‐CoA desaturase 1 (SCD1) enhances the antitumor function of CD8 + T cells indirectly via restoring production of DC recruiting chemokines by cancer cells and subsequent induction of antitumor CD8 + T cells. In this study, we investigated the molecular mechanism of direct enhancing effects of SCD1 inhibitors on CD8 + T cells. In vitro treatment of CD8 + T cells with SCD1 inhibitors enhanced IFN‐γ production and cytotoxic activity of T cells along with decreased oleic acid and esterified cholesterol, which is generated by cholesterol esterase, acetyl‐CoA acetyltransferase 1 (ACAT1), in CD8 + T cells. The addition of oleic acid or cholesteryl oleate reversed the enhanced functions of CD8 + T cells treated with SCD1 inhibitors. Systemic administration of SCD1 inhibitor to MCA205 tumor‐bearing mice enhanced IFN‐γ production of tumor‐infiltrating CD8 + T cells, in which oleic acid and esterified cholesterol, but not cholesterol, were decreased. These results indicated that SCD1 suppressed effector functions of CD8 + T cells through the increased esterified cholesterol in an ACAT1‐dependent manner, and SCD1 inhibition enhanced T cell activity directly through decreased esterified cholesterol. Finally, SCD1 inhibitors or ACAT1 inhibitors synergistically enhanced the antitumor effects of anti‐PD‐1 antibody therapy or CAR‐T cell therapy in mouse tumor models. Therefore, the SCD1–ACAT1 axis is regulating effector functions of CD8 + T cells, and SCD1 inhibitors, and ACAT1 inhibitors are attractive drugs for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan.
- Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
- Nihon University School of Medicine, Tokyo, Japan.
- Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
- Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
ORCID-Profile: Yuki Katoh
Förderung
- Japan Agency for Medical Research and Development
- Kobayashi Foundation for Cancer Research
- Ministry of Education, Culture, Sports, Science and Technology
- Nihon University Research Grant-in-aid for Early Career Scientists (2021)
- Nihon University School of Medicine 50th Anniversary Fund Research Grant (2021)
Zitieren
APA
Sugi, T., Katoh, Y., Ikeda, T., Seta, D., Iwata, T., Nishio, H., Sugawara, M., Kato, D., Katoh, K., Kawana, K., Yaguchi, T., Kawakami, Y., & Hirai, S. (2024). SCD1 inhibition enhances the effector functions of CD8 + T cells via ACAT1 ‐dependent reduction of esterified cholesterol. Cancer Science. https://doi.org/10.1111/cas.15999
Vancouver
Sugi T, Katoh Y, Ikeda T, Seta D, Iwata T, Nishio H, et al. SCD1 inhibition enhances the effector functions of CD8 + T cells via ACAT1 ‐dependent reduction of esterified cholesterol. Cancer Science. 2024. doi:10.1111/cas.15999
BibTeX
@article{Sugi2024,
author = {Sugi, Toshihiro and Katoh, Yuki and Ikeda, Toshikatsu and Seta, Daichi and Iwata, Takashi and Nishio, Hiroshi and Sugawara, Masaki and Kato, Daiki and Katoh, Kanoko and Kawana, Kei and Yaguchi, Tomonori and Kawakami, Yutaka and Hirai, Shuichi},
title = {SCD1 inhibition enhances the effector functions of CD8 + T cells via ACAT1 ‐dependent reduction of esterified cholesterol},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.15999}
}
EUVIMED